LV10924A - Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai - Google Patents

Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai

Info

Publication number
LV10924A
LV10924A LV950158A LV950158A LV10924A LV 10924 A LV10924 A LV 10924A LV 950158 A LV950158 A LV 950158A LV 950158 A LV950158 A LV 950158A LV 10924 A LV10924 A LV 10924A
Authority
LV
Latvia
Prior art keywords
treatment
free radical
disease prevention
synthetic catalytic
acceptors used
Prior art date
Application number
LV950158A
Other languages
English (en)
Other versions
LV10924B (en
Inventor
Bernard Malfroy-Camine
Michel Baudry
Original Assignee
Eukarion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eukarion Inc filed Critical Eukarion Inc
Publication of LV10924A publication Critical patent/LV10924A/lv
Publication of LV10924B publication Critical patent/LV10924B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Hydrogenated Pyridines (AREA)
LVP-95-158A 1992-12-07 1995-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease LV10924B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/987,474 US5403834A (en) 1992-12-07 1992-12-07 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
PCT/US1993/011857 WO1994013300A1 (en) 1992-12-07 1993-12-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Publications (2)

Publication Number Publication Date
LV10924A true LV10924A (lv) 1995-12-20
LV10924B LV10924B (en) 1996-10-20

Family

ID=25533292

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-158A LV10924B (en) 1992-12-07 1995-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Country Status (20)

Country Link
US (2) US5403834A (lv)
EP (2) EP0746321B1 (lv)
JP (1) JP3502099B2 (lv)
KR (1) KR20040004386A (lv)
AT (1) ATE290867T1 (lv)
AU (1) AU697399B2 (lv)
CA (1) CA2150937C (lv)
CZ (1) CZ296288B6 (lv)
DE (1) DE69333775T2 (lv)
GB (2) GB2277873B (lv)
HU (1) HU225109B1 (lv)
LV (1) LV10924B (lv)
NO (1) NO319454B1 (lv)
NZ (1) NZ259200A (lv)
OA (1) OA10165A (lv)
PL (1) PL175446B1 (lv)
RU (1) RU2157213C2 (lv)
SK (1) SK74595A3 (lv)
UA (1) UA27949C2 (lv)
WO (1) WO1994013300A1 (lv)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653685A (en) * 1990-10-10 1997-08-05 Lrt, Inc. Method of providing circulation via lung expansion and deflation
USRE36460E (en) * 1990-10-10 1999-12-21 Life Science Holdings, Inc. Method of providing circulation via lung expansion and deflation
US5696109A (en) * 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US7582786B2 (en) * 1992-12-07 2009-09-01 Eukarion Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5834509A (en) * 1992-12-07 1998-11-10 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
PL317192A1 (en) * 1994-05-13 1997-03-17 Monsanto Co Methods of using pernitrite decomposition catalyst and their pharmaceutic compositions
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
WO1996004311A1 (en) * 1994-08-03 1996-02-15 University Of Alabama At Birmingham Research Foundation Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
US5900433A (en) * 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
CA2247876A1 (en) * 1996-03-08 1997-09-12 Ronald M. Klatz Liquid ventilation method and apparatus
WO1998010057A1 (en) 1996-09-06 1998-03-12 Emory University Methods for testing compounds for use as therapeutic antioxidants
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
US6214817B1 (en) 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
AT409306B (de) * 1997-10-03 2002-07-25 Hoffmann La Roche Optisch chemischer sensor
CA2309154C (en) 1997-11-03 2010-02-16 Duke University Substituted porphyrins
CA2249778A1 (en) * 1997-12-15 1999-06-15 Bayer Corporation Competitive apo-peroxidase assay
GB9817845D0 (en) 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
US7816403B2 (en) * 1998-09-08 2010-10-19 University Of Utah Research Foundation Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
EP1155019B1 (en) 1999-01-25 2005-12-07 National Jewish Medical and Research Center Substituted porphyrins and their therapeutic use
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US20040110722A1 (en) * 1999-05-27 2004-06-10 Ornberg Richard L. Modified hyaluronic acid polymers
ATE383364T1 (de) * 1999-05-27 2008-01-15 Monsanto Co Biomaterialien, modifiziert mit superoxid- dismutase imitatoren
US6179804B1 (en) * 1999-08-18 2001-01-30 Oxypatch, Llc Treatment apparatus for wounds
CN1243000C (zh) * 2000-02-11 2006-02-22 研究发展基金会 生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途
US20040047852A1 (en) * 2001-03-02 2004-03-11 Kennedy Thomas Preston Method of treating cancer
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
WO2002043514A1 (en) * 2000-11-28 2002-06-06 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
US6589948B1 (en) * 2000-11-28 2003-07-08 Eukarion, Inc. Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
US6692458B2 (en) * 2000-12-19 2004-02-17 Edwards Lifesciences Corporation Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
US20030050297A1 (en) * 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
ITPI20010014A1 (it) * 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
KR100681326B1 (ko) * 2001-04-20 2007-02-15 주식회사 중외제약 신규한 망간-키랄성 화합물 및 그의 이용방법
JP2005508864A (ja) * 2001-06-01 2005-04-07 ナショナル・ジュウィッシュ・メディカル・アンド・リサーチ・センター 糖尿病の治療、または移植術における使用、または免疫寛容の誘導のためのオキシダントスカベンジャー
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010154A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
WO2003053407A1 (en) * 2001-12-19 2003-07-03 Research Development Foundation Liposomal delivery of vitamin e based compounds
US7485721B2 (en) * 2002-06-07 2009-02-03 Duke University Substituted porphyrins
US6835387B2 (en) * 2002-06-11 2004-12-28 Scimed Life Systems, Inc. Sustained release of superoxide dismutase mimics from implantable or insertable medical devices
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003263948A1 (en) * 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
RU2361615C2 (ru) * 2002-12-09 2009-07-20 Абраксис Байосайенс, Ллс. Композиции и способы доставки фармакологических агентов
JP2006524632A (ja) 2002-12-09 2006-11-02 アメリカン バイオサイエンス、インコーポレイテッド 組成物及び薬物送達方法
EP1569511A1 (en) * 2002-12-11 2005-09-07 CryoLife, Inc. Radical retardant cryopreservation solutions
WO2005030137A2 (en) * 2003-09-24 2005-04-07 The University Of Toledo, A University Instrumentality Of The State Of Ohio Improving biomechanical performance of irradiated biological material
US20050100537A1 (en) * 2003-11-10 2005-05-12 Evans Gregory S. Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
US20090099150A1 (en) * 2005-01-19 2009-04-16 Daniela Salvemini Methotrexate Combinations For Treating Inflammatory Diseases
WO2006117405A1 (en) * 2005-05-04 2006-11-09 Coty Prestige Lancaster Group Gmbh The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
EP2345974B1 (en) * 2006-06-28 2014-08-06 IHI Corporation Magnetically guidable compound
US8252780B2 (en) * 2006-12-01 2012-08-28 Women & Infants' Hospital Organometallic complexes as therapeutic agents
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
CA2725012C (en) 2008-05-23 2019-05-07 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
WO2010058280A1 (ja) * 2008-11-20 2010-05-27 株式会社Ihi 自己磁性金属サレン錯体化合物
KR101050273B1 (ko) * 2008-11-21 2011-07-19 세종대학교산학협력단 살렌 전이금속 착화합물, 및 그 제조 방법
JP5736367B2 (ja) * 2010-04-06 2015-06-17 株式会社Ihi 金属サレン錯体誘導体及びその製造方法
EP2564852B1 (en) * 2010-04-28 2015-02-25 IHI Corporation Anti-brain-tumor drug
WO2011151978A1 (ja) * 2010-06-01 2011-12-08 株式会社Ihi 蛍光色素材料及びその使用方法
EP2944627B1 (en) * 2010-12-21 2021-01-27 IHI Corporation Nanometersized metal salen complex compounds, their preparation and their use as systemic antitumor agents
JP5873656B2 (ja) 2011-06-13 2016-03-01 株式会社Ihi 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤
JP6017766B2 (ja) * 2011-07-26 2016-11-02 株式会社Ihi 新規な金属サレン錯体化合物の抗がん剤
JP6155190B2 (ja) * 2011-10-04 2017-06-28 株式会社Ihi 金属サレン錯体化合物応答性薬剤及び金属サレン錯体化合物の体内挙動制御システム
JP6046338B2 (ja) * 2011-10-27 2016-12-14 株式会社Ihi ラジカル抑制剤
KR102086022B1 (ko) * 2012-01-05 2020-03-06 플레드파르마 에이비 칼망가포디피르, 신규 화학 물질 및 기타 혼합 금속 착물, 제조방법, 조성물 및 치료방법
CN108030926B (zh) * 2017-12-15 2021-07-13 武汉工程大学 一种具有高的SOD酶活性的Salen型锰配合物-壳聚糖复合材料及其制备方法
RU2699040C1 (ru) * 2018-07-23 2019-09-03 Федеральное государственное бюджетное учреждение науки "Уральский научно-практический центр радиационной медицины Федерального медико-биологического агентства" (ФГБУН УНПЦ РМ ФМБА России) Способ экстренной профилактики и лечения острой лучевой болезни (варианты)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5106841A (en) * 1986-05-13 1992-04-21 Chai-Tech Corporation Antiviral compositions and method for their use
US5223538A (en) * 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
CA2116335C (en) * 1991-08-26 1999-08-24 Eric N. Jacobsen Chiral catalysts, catalytic oxidation and disproportionation reactions, and methods of producing epoxychromans and taxol
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Also Published As

Publication number Publication date
GB2277873A (en) 1994-11-16
UA27949C2 (uk) 2000-10-16
NO952237L (no) 1995-08-01
US5403834A (en) 1995-04-04
RU2157213C2 (ru) 2000-10-10
AU697399B2 (en) 1998-10-08
GB2305107A (en) 1997-04-02
NO952237D0 (no) 1995-06-06
PL175446B1 (pl) 1998-12-31
HU225109B1 (en) 2006-06-28
NO319454B1 (no) 2005-08-15
DE69333775D1 (de) 2005-04-21
JPH08504211A (ja) 1996-05-07
CA2150937A1 (en) 1994-06-23
GB2305107B (en) 1997-05-14
CZ296288B6 (cs) 2006-02-15
EP0746321B1 (en) 2005-03-16
HU9501644D0 (en) 1995-08-28
DE69333775T2 (de) 2006-04-06
OA10165A (en) 1996-12-18
JP3502099B2 (ja) 2004-03-02
KR20040004386A (ko) 2004-01-13
LV10924B (en) 1996-10-20
CZ144295A3 (en) 1996-10-16
SK74595A3 (en) 1996-05-08
NZ259200A (en) 1997-06-24
GB9621087D0 (en) 1996-11-27
EP1642583A2 (en) 2006-04-05
PL309334A1 (en) 1995-10-02
HUT72967A (en) 1996-06-28
ATE290867T1 (de) 2005-04-15
AU5741994A (en) 1994-07-04
CA2150937C (en) 2007-08-14
EP0746321A4 (en) 2001-05-09
US5827880A (en) 1998-10-27
EP0746321A1 (en) 1996-12-11
WO1994013300A1 (en) 1994-06-23
GB2277873B (en) 1997-05-14
GB9415050D0 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
LV10924A (lv) Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai
TW272940B (en) /
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
DE69931766D1 (de) Antitumorale mittel
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
ES2153862T3 (es) Bisulfan de administracion parenteral para el tratamiento de enfermedades malignas.
SE7502341L (lv)
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
DK0983072T3 (da) Fruktanholdige sammensætninger til forebyggelse og behandling af coloncancer
IE893618L (en) Lactamimides in the treatment of drug-resistant protozoal¹infections
GB9400691D0 (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
CA2033249A1 (en) Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
IS4198A (is) Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
GB9004348D0 (en) New use of catechol derivatives and their physiologically acceptable salts and esters
NO874241D0 (no) Terapeutisk aktive salter.
ES2150418T3 (es) Composiciones farmaceuticas que comprenden calcitonina.
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
EP0182569A3 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages
IT1244360B (it) Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale
UA10259A (uk) Протинабряковий лікарський препарат "нейрополіосм"
IT1251993B (it) Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico
YU104192A (sh) 2-(4-hidroksipiperiodino)-1-alkanol derivati